Literature DB >> 33917351

Cancer-Associated Adipocytes in Breast Cancer: Causes and Consequences.

Ilona Rybinska1, Nunzia Mangano1, Elda Tagliabue1, Tiziana Triulzi1.   

Abstract

Breast cancer progression is highly dependent on the heterotypic interaction between tumor cells and stromal cells of the tumor microenvironment. Cancer-associated adipocytes (CAAs) are emerging as breast cancer cell partners favoring proliferation, invasion, and metastasis. This article discussed the intersection between extracellular signals and the transcriptional cascade that regulates adipocyte differentiation in order to appreciate the molecular pathways that have been described to drive adipocyte dedifferentiation. Moreover, recent studies on the mechanisms through which CAAs affect the progression of breast cancer were reviewed, including adipokine regulation, metabolic reprogramming, extracellular matrix remodeling, and immune cell modulation. An in-depth understanding of the complex vicious cycle between CAAs and breast cancer cells is crucial for designing novel strategies for new therapeutic interventions.

Entities:  

Keywords:  adipocyte dedifferentiation; adipogenesis; breast cancer; cancer-associated adipocytes (CAA); signaling

Year:  2021        PMID: 33917351     DOI: 10.3390/ijms22073775

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  10 in total

Review 1.  Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy.

Authors:  Melania Lo Iacono; Chiara Modica; Gaetana Porcelli; Ornella Roberta Brancato; Giampaolo Muratore; Paola Bianca; Miriam Gaggianesi; Alice Turdo; Veronica Veschi; Matilde Todaro; Simone Di Franco; Giorgio Stassi
Journal:  Biomolecules       Date:  2022-05-14

Review 2.  The pleiotropic roles of adipocyte secretome in remodeling breast cancer.

Authors:  Xiaomei Zhou; Jun Zhang; Wenchang Lv; Chongru Zhao; Yu Xia; Yiping Wu; Qi Zhang
Journal:  J Exp Clin Cancer Res       Date:  2022-06-14

3.  MCF-7 Drug Resistant Cell Lines Switch Their Lipid Metabolism to Triple Negative Breast Cancer Signature.

Authors:  Jose Adriá-Cebrián; Sandra Guaita-Esteruelas; Eric W-F Lam; Marta Rodríguez-Balada; Jordi Capellades; Josefa Girona; Ana Maria Jimenez-Santamaria; Oscar Yanes; Luís Masana; Josep Gumà
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

Review 4.  Extracellular vesicle-mediated transport: Reprogramming a tumor microenvironment conducive with breast cancer progression and metastasis.

Authors:  Dara Brena; Ming-Bo Huang; Vincent Bond
Journal:  Transl Oncol       Date:  2021-11-25       Impact factor: 4.243

5.  Cancer-associated adipocytes promote the invasion and metastasis in breast cancer through LIF/CXCLs positive feedback loop.

Authors:  Chong Zhou; Xi He; Chang Tong; Honghui Li; Caifeng Xie; Yudong Wu; Lieliang Wang; Xiaohua Yan; Daya Luo; Yunpeng Tang; Zhongman Cheng; Xiangyang Xiong
Journal:  Int J Biol Sci       Date:  2022-01-16       Impact factor: 6.580

6.  EGCG Prevents the Onset of an Inflammatory and Cancer-Associated Adipocyte-like Phenotype in Adipose-Derived Mesenchymal Stem/Stromal Cells in Response to the Triple-Negative Breast Cancer Secretome.

Authors:  Narjara Gonzalez Suarez; Yuniel Fernandez-Marrero; Sima Torabidastgerdooei; Borhane Annabi
Journal:  Nutrients       Date:  2022-03-05       Impact factor: 5.717

Review 7.  Altered Adipokine Expression in Tumor Microenvironment Promotes Development of Triple Negative Breast Cancer.

Authors:  Efthymia Papakonstantinou; Zoi Piperigkou; Nikos K Karamanos; Vasiliki Zolota
Journal:  Cancers (Basel)       Date:  2022-08-26       Impact factor: 6.575

8.  Special Issue: "Unraveling the Involvement of Adipose Tissue in Breast Cancer Progression".

Authors:  Tiziana Triulzi
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

Review 9.  Local Biomarkers Involved in the Interplay between Obesity and Breast Cancer.

Authors:  Jonas Busk Holm; Ann H Rosendahl; Signe Borgquist
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

Review 10.  Impact of Immune Cell Heterogeneity on HER2+ Breast Cancer Prognosis and Response to Therapy.

Authors:  Milena Perrone; Giovanna Talarico; Claudia Chiodoni; Sabina Sangaletti
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.